CHEMORADIOTHERAPY
Clinical trials for CHEMORADIOTHERAPY explained in plain language.
Never miss a new study
Get alerted when new CHEMORADIOTHERAPY trials appear
Sign up with your email to follow new studies for CHEMORADIOTHERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop deadly esophageal Cancer's return
Disease control Not yet recruitingThis study is for people with a type of esophageal cancer who have just finished standard chemoradiation treatment. It tests whether taking two drugs (toripalimab and capecitabine) for a longer period as 'maintenance therapy' can help keep the cancer from growing back and help pa…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
Targeted drug trial aims to extend remission for Tough-to-Treat lung cancer
Disease control Not yet recruitingThis study is testing whether adding the targeted drug ensartinib after standard chemoradiation can better control advanced, inoperable lung cancer in patients with a specific genetic change (ALK mutation). It will involve about 45 patients who have completed initial treatment wi…
Matched conditions: CHEMORADIOTHERAPY
Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
Better scans could help rectal cancer patients avoid unnecessary surgery
Diagnosis Not yet recruitingThis study aims to develop better MRI scan methods to predict which rectal cancer patients have completely responded to initial treatment and can safely avoid major surgery. Researchers will analyze MRI data from about 115 patients to create a tool that more accurately detects ti…
Matched conditions: CHEMORADIOTHERAPY
Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC